BH Kang, M Tavecchio, HL Goel, CC Hsieh… - British journal of …, 2011 - nature.com We tested the efficacy of a novel mitochondrial-targeted, small-molecule Hsp90 inhibitor, Gamitrinib (GA mitochondrial matrix inhibitor), in the Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model. The TRAMP mice receiving 3-week or 5-week systemic treatment with ... Cited by 1 - Related articles - All 4 versions
L Klotz… - The New England journal of medicine, 2011 - ncbi.nlm.nih.gov 1. N Engl J Med. 2011 Aug 11;365(6):569. Early prostate cancer--treat or watch? Klotz L, Thompson I. Comment on N Engl J Med. 2011 May 5;364(18):1708-17. PMID: 21830972 [PubMed - in process]. Publication Types: Comment; Letter.
[PDF] from natap.orgA Bill-Axelson, L Holmberg, M Ruutu… - New England journal of …, 2011 - nejm.org During a median of 12.8 years, 166 of the 347 men in the radical-prostatectomy group and 201 of the 348 in the watchful-waiting group died (P=0.007). In the case of 55 men assigned to surgery and 81 men assigned to watchful waiting, death was due to prostate cancer. This yielded ... Cited by 12 - Related articles - All 6 versions
J Gudmundsson - Oncology Times, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... According to a new study in December, ...
[HTML] from embryomas.netMF Berger, MS Lawrence, F Demichelis, Y Drier… - Nature, 2011 - nature.com Prostate cancer is the second most common cause of male cancer deaths in the United States. However, the full range of prostate cancer genomic alterations is incompletely characterized. Here we present the complete sequence of seven primary human prostate ... Cited by 19 - Related articles - All 9 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
